42 results
6-K
EX-99.2
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
for repeated dose administration while reducing the potential need for the use of opiates.
Our strategy is to incorporate generic drugs with our
424B3
PRFX
PainReform Ltd
17 Apr 24
Prospectus supplement
4:15pm
statements regarding events, conditions, and financial trends that may affect our plan of operation, business strategy, operating results, and financial
424B4
PRFX
PainReform Ltd
17 Apr 24
Prospectus supplement with pricing info
4:14pm
administration while reducing the potential need for the use of opiates.
Our strategy is to incorporate generic drugs with our proprietary extended-release … or investment strategy involving securities (including account recommendations) to a retail customer, shall act in the best interest of the retail customer
F-1/A
PRFX
PainReform Ltd
15 Apr 24
Registration statement (foreign) (amended)
9:41am
the need for repeated dose administration while reducing the potential need for the use of opiates.
Our strategy is to incorporate generic drugs … transaction or investment strategy involving securities (including account recommendations) to a retail customer, shall act in the best interest of the retail
POS AM
PRFX
PainReform Ltd
13 Mar 24
Prospectus update (post-effective amendment)
8:00am
pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates.
Our strategy is to incorporate
F-1
c531by 7tjk0y
1 Mar 24
Registration statement (foreign)
4:34pm
424B3
52p kalrj9
19 Jan 24
Prospectus supplement
4:30pm
F-3
twl241u2158xc3s
12 Jan 24
Shelf registration (foreign)
4:15pm
424B3
0l1b flf53b4ralhdks
27 Dec 23
Prospectus supplement
4:04pm
6-K
EX-99.2
w6gx 0qv06r2umg8o
15 Nov 23
Condensed Financial Statements
4:09pm
424B3
w0znyf mpqh
5 Sep 23
Prospectus supplement
4:16pm
F-1
yskkjyw2tvloas 6fvos
25 Aug 23
Registration statement (foreign)
4:15pm
6-K
EX-99.2
isa8qpv
10 Aug 23
Current report (foreign)
4:18pm
424B5
e63xo pywgilg6z
18 Jul 23
Prospectus supplement for primary offering
11:59am
424B5
7bp93mqg1eb
14 Jul 23
Prospectus supplement for primary offering
12:26pm
6-K
EX-99.2
5d40f
15 May 23
Condensed Financial Statements
4:51pm
6-K
EX-99.2
kk64oeh6yv 9odljth
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
EX-99.2
kqb8d
15 Aug 22
Current report (foreign)
6:16pm
6-K
EX-99.2
fkpu4oab
16 May 22
Condensed Financial Statements
4:31pm